• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BLITZ-HF:一项全国性的倡议,旨在评估和改善急性和慢性心力衰竭指南的依从性。

BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines.

机构信息

Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy.

Heart Care Foundation, ANMCO Research Center, Florence, Italy.

出版信息

Eur J Heart Fail. 2022 Nov;24(11):2078-2089. doi: 10.1002/ejhf.2605. Epub 2022 Jul 21.

DOI:10.1002/ejhf.2605
PMID:35785461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10084144/
Abstract

AIMS

To assess adherence to guideline recommendations among a large network of Italian cardiology sites in the management of acute and chronic heart failure (HF) and to evaluate if an ad-hoc educational intervention can improve their performance on several pharmacological and non-pharmacological indicators.

METHODS AND RESULTS

BLITZ-HF was a cross-sectional study based on a web-based recording system with pop-up reminders on guideline recommendations used during two 3-month enrolment periods carried out 3 months apart (Phase 1 and 3), interspersed by face-to-face macro-regional benchmark analyses and educational meetings (Phase 2). Overall, 7218 patients with acute and chronic HF were enrolled at 106 cardiology sites. During the enrolment phases, 3920 and 3298 patients were included, respectively, 84% with chronic HF and 16% with acute HF in Phase 1, and 74% with chronic HF and 26% with acute HF in Phase 3. At baseline, adherence to guideline recommendations was already overall high for most indicators. Among acute HF patients, an improvement was obtained in three out of eight indicators, with a significant rise in echocardiographic evaluation. Among chronic HF patients with HF and preserved or mid-range ejection fraction, performance increased in two out of three indicators: creatinine and echocardiographic evaluations. An overall performance improvement was observed in six out of nine indicators in ambulatory HF with reduced ejection fraction patients with a significant increase in angiotensin receptor-neprilysin inhibitor prescription rates.

CONCLUSIONS

Within a context of an already elevated level of adherence to HF guideline recommendations, a structured multifaceted educational intervention could be useful to improve performance on specific indicators. Extending this approach to other non-cardiology healthcare professionals, who usually manage patients with HF, should be considered.

摘要

目的

评估意大利心脏病学网络中大量站点在急性和慢性心力衰竭(HF)管理中对指南建议的遵循情况,并评估专门的教育干预是否可以改善他们在几个药理学和非药理学指标上的表现。

方法和结果

BLITZ-HF 是一项基于网络的记录系统的横断面研究,该系统在两次 3 个月的登记期(第 1 期和第 3 期)中使用弹出式提醒,提示指南建议,两次登记期相隔 3 个月,期间穿插面对面的大区基准分析和教育会议(第 2 期)。共有 106 个心脏病学站点的 7218 名急性和慢性 HF 患者入组。在登记期内,分别纳入了 3920 名和 3298 名患者,第 1 期 84%为慢性 HF 患者,16%为急性 HF 患者,第 3 期 74%为慢性 HF 患者,26%为急性 HF 患者。基线时,大多数指标对指南建议的遵循已经很高。在急性 HF 患者中,八项指标中有三项得到了改善,超声心动图评估有显著提高。射血分数保留或中间范围的慢性 HF 患者中,有两项指标的表现得到了改善:肌酐和超声心动图评估。射血分数降低的慢性 HF 患者在九个指标中的六个指标中观察到总体表现改善,血管紧张素受体-脑啡肽酶抑制剂处方率显著增加。

结论

在已经遵循 HF 指南建议的水平较高的情况下,结构化的多方面教育干预可能有助于改善特定指标的表现。应该考虑将这种方法扩展到其他通常管理 HF 患者的非心脏病学医疗保健专业人员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/5ced8c34e701/EJHF-24-2078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/5604a69fe39d/EJHF-24-2078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/1b3087dbe825/EJHF-24-2078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/5ced8c34e701/EJHF-24-2078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/5604a69fe39d/EJHF-24-2078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/1b3087dbe825/EJHF-24-2078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8be/10084144/5ced8c34e701/EJHF-24-2078-g001.jpg

相似文献

1
BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines.BLITZ-HF:一项全国性的倡议,旨在评估和改善急性和慢性心力衰竭指南的依从性。
Eur J Heart Fail. 2022 Nov;24(11):2078-2089. doi: 10.1002/ejhf.2605. Epub 2022 Jul 21.
2
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).改善门诊心脏病学实践中心力衰竭的循证护理:改善门诊心力衰竭证据治疗应用注册研究(IMPROVE HF)的主要结果。
Circulation. 2010 Aug 10;122(6):585-96. doi: 10.1161/CIRCULATIONAHA.109.934471. Epub 2010 Jul 26.
3
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.心力衰竭的住院或门诊患者是否按照欧洲心脏病学会指南进行治疗?来自 ESC 心力衰竭长期注册研究的 12440 例患者的证据。
Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26.
4
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.冠心病患者的心力衰竭:患病率、特征及指南实施情况——德国EuroAspire IV队列研究结果
BMC Cardiovasc Disord. 2017 May 5;17(1):108. doi: 10.1186/s12872-017-0543-0.
5
[The new ESC Guidelines for acute and chronic heart failure 2016].[2016年欧洲心脏病学会急性和慢性心力衰竭新指南]
Herz. 2016 Dec;41(8):655-663. doi: 10.1007/s00059-016-4496-3.
6
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.当代射血分数降低的慢性心力衰竭的药物治疗:CHECK-HF 注册研究。
JACC Heart Fail. 2019 Jan;7(1):13-21. doi: 10.1016/j.jchf.2018.10.010.
7
Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service.在心血管门诊服务中,根据指南对门诊心力衰竭患者进行处方。
Int J Clin Pharm. 2021 Aug;43(4):1082-1089. doi: 10.1007/s11096-020-01220-z. Epub 2021 Jan 7.
8
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.血管紧张素受体脑啡肽酶抑制剂治疗射血分数保留心力衰竭:PARAGON-HF 试验的原理和设计。
JACC Heart Fail. 2017 Jul;5(7):471-482. doi: 10.1016/j.jchf.2017.04.013. Epub 2017 Jun 26.
9
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).专门的心衰诊所对门诊心脏病学实践中推荐疗法的实施的影响:来自改善门诊环境中基于证据的心衰治疗应用的注册研究(IMPROVE HF)的结果。
Am Heart J. 2010 Feb;159(2):238-44. doi: 10.1016/j.ahj.2009.11.022.
10
Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands : Design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry.荷兰10910例慢性心力衰竭患者的真实世界心力衰竭管理:基于欧洲心脏病学会(ESC)慢性心力衰竭指南的心脏病学实践质量项目(CHECK-HF)注册研究的设计与原理
Neth Heart J. 2018 May;26(5):272-279. doi: 10.1007/s12471-018-1103-7.

引用本文的文献

1
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry).射血分数降低的心力衰竭患者的指南导向药物治疗实施(优化心力衰竭注册研究)
ESC Heart Fail. 2025 Jun;12(3):1786-1795. doi: 10.1002/ehf2.15172. Epub 2025 Feb 5.
2
Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum.优化心力衰竭患者指南指导下药物治疗处方率的数字解决方案:欧洲心脏病学会电子心脏病学工作组、欧洲心脏病学会心力衰竭协会、欧洲心脏病学会心血管护理及相关专业协会、欧洲心脏病学会数字健康委员会、欧洲心脏病学会心脏肿瘤学委员会及欧洲心脏病学会患者论坛的临床共识声明
Eur Heart J Digit Health. 2024 Aug 30;5(6):670-682. doi: 10.1093/ehjdh/ztae064. eCollection 2024 Nov.

本文引用的文献

1
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.2021 ESC 急性和慢性心力衰竭诊断和治疗指南:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断和治疗工作组制定。特别感谢欧洲心脏病学会心力衰竭协会(HFA)的贡献。
Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333.
2
Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.聚磺苯乙烯钠用于心力衰竭患者接受肾素-血管紧张素-醛固酮系统抑制剂治疗时的高钾血症管理:DIAMOND 试验的设计和原理。
Eur J Heart Fail. 2022 Jan;24(1):230-238. doi: 10.1002/ejhf.2386. Epub 2021 Dec 9.
3
3
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.中国心力衰竭患者的性能指标与临床结局之间的关联:HERO研究结果
Clin Cardiol. 2024 Feb;47(2):e24233. doi: 10.1002/clc.24233.
4
Digital Solutions to Optimize Guideline-Directed Medical Therapy Prescriptions in Heart Failure Patients: Current Applications and Future Directions.数字解决方案优化心力衰竭患者指南导向的药物治疗处方:当前应用与未来方向。
Curr Heart Fail Rep. 2024 Apr;21(2):147-161. doi: 10.1007/s11897-024-00649-x. Epub 2024 Feb 16.
5
Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors.血管紧张素-肾素-醛固酮系统抑制剂治疗患者高钾血症的管理建议。
Intern Emerg Med. 2024 Mar;19(2):295-306. doi: 10.1007/s11739-023-03427-0. Epub 2023 Sep 29.
6
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure.心力衰竭中 SGLT2 抑制剂的实用指南。
Am J Cardiovasc Drugs. 2023 Nov;23(6):609-621. doi: 10.1007/s40256-023-00601-9. Epub 2023 Aug 24.
7
Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis.2019年冠状病毒病时代的超声心动图:诊断与预后的单一工具
J Cardiovasc Echogr. 2023 Jan-Mar;33(1):10-16. doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29.
8
Natural Course of COVID-19 and Independent Predictors of Mortality.新型冠状病毒肺炎的自然病程及死亡的独立预测因素
Biomedicines. 2023 Mar 17;11(3):939. doi: 10.3390/biomedicines11030939.
Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.急性心力衰竭充血和灌注状态 - 临床分类对住院和长期结局的影响;来自 ESC-EORP-HFA 心力衰竭长期注册研究的见解。
Eur J Heart Fail. 2019 Nov;21(11):1338-1352. doi: 10.1002/ejhf.1492. Epub 2019 May 24.
4
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的药物治疗滴定。
J Am Coll Cardiol. 2019 May 21;73(19):2365-2383. doi: 10.1016/j.jacc.2019.02.015. Epub 2019 Mar 4.
5
Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.急诊科和心内科病房心房颤动的管理:BLITZ AF 研究。
Europace. 2019 Feb 1;21(2):230-238. doi: 10.1093/europace/euy166.
6
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.射血分数降低的心力衰竭的药物治疗:CHAMP-HF 注册研究。
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.
7
Effectiveness of implementation interventions in improving physician adherence to guideline recommendations in heart failure: a systematic review.实施干预措施在提高医生对心力衰竭指南建议的依从性方面的有效性:一项系统评价。
BMJ Open. 2018 Mar 6;8(3):e017765. doi: 10.1136/bmjopen-2017-017765.
8
Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.从医院出院的心衰患者过渡性护理服务的效果比较:系统评价和网络荟萃分析。
Eur J Heart Fail. 2017 Nov;19(11):1427-1443. doi: 10.1002/ejhf.765. Epub 2017 Feb 24.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
10
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.遵循心力衰竭指南建议和医院质量指标所需的药物起始负担。
Circulation. 2015 Oct 6;132(14):1347-53. doi: 10.1161/CIRCULATIONAHA.115.014281. Epub 2015 Aug 27.